WASHINGTON, June 8 (UPI) -- A "morning-after pill" that reportedly is effective for five days after sex is being considered for approval in the United States, officials said.
A Food and Drug Administration advisory panel is to meet June 17 to consider whether the agency should approve ulipristal acetate for sale in U.S. markets.